false
0001990446
0001990446
2026-03-26
2026-03-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities
and Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 26, 2026
Commission File Number 000-56640
TRANS
AMERICAN AQUACULTURE, INC.
(Exact name of small business issuer as specified
in its charter)
| Colorado |
|
02-0685828 |
|
(State or other jurisdiction
of incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
1022 Shadyside Lane
Dallas, TX 75223
(Address of principal executive offices)
(972) 358-6037
(Issuer’s telephone number)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instructions A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Not applicable. |
|
|
|
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 1.01 |
Entry into a Material Definitive Agreement. |
Securities Purchase
Agreement with GHS Investments
On March 26, 2026, Trans American Aquaculture,
Inc., a Colorado corporation (the “Company”), entered into a Securities Purchase Agreement (the “SPA”)
with GHS Investments LLC (“GHS”) pursuant to which the Company agreed to sell to GHS, at the initial closing, fifty-nine
(59) shares of Series D Preferred Stock at a purchase price of $1,000 per share, for an aggregate purchase price of $59,000 (with $3,000
in legal fees reimbursable to GHS, which may be paid in cash or in shares of Series D Preferred Stock). Each share of Series D Preferred
Stock has a stated value of $1,200 per share. At the initial closing on March 26, 2026, GHS purchased 59 shares of Series D Preferred
Stock and was issued an additional six shares of Series D Preferred Stock as commitment shares. Subject to the terms of the SPA, including
the filing by the Company of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and satisfaction of applicable
equity conditions, the Company may sell and GHS may purchase, at GHS's discretion, up to an additional 13 shares of Series D Preferred
Stock in one or more additional closings at $1,000 per share. The Series D Preferred Stock accrues dividends at a rate of eight percent
per annum of the stated value, paid quarterly in cash or, at the Company's discretion, in additional shares of Series D Preferred Stock.
In addition, pursuant to the SPA and at each closing,
the Company agreed to issue to GHS warrants to purchase shares of the Company’s Common Stock equal to 50% of the number of Conversion
Shares issuable upon conversion of the shares of Series D Preferred Stock purchased by GHS, with an exercise price equal to 115% of the
closing bid price of the Common Stock on the trading day immediately preceding each issuance. At the initial closing on March 26, 2026,
the Company issued to GHS a warrant to purchase up to 243,750,000 shares of Common Stock at an exercise price of $0.000161 per share,
expiring on March 26, 2031. The warrants contain full-ratchet anti-dilution adjustment provisions and a beneficial ownership limitation
of 4.99% (subject to increase to up to 9.99% upon notice by the holder).
| Item 3.02 |
Unregistered Sales of Equity Securities. |
The disclosure in Item
1.01 is incorporated by reference into this Item 3.02 herein.
The sales of Series D Preferred Stock and warrants
were made in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule
506 of Regulation D promulgated thereunder, and were made without general solicitation or advertising. The purchaser represented that
it was an “accredited investor” with access to information about the Company sufficient to evaluate the investment and that
the securities were being acquired without a view to distribution or resale in violation of the Securities Act. The securities offered
have not been registered under the Securities Act and may not be offered or sold in the United States without registration or an applicable
exemption from the registration requirements of the Securities Act. No sales commissions were paid in connection with the sales of these
securities.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
Trans American Aquaculture, Inc.
|
| |
|
| Date: April 2, 2026 |
By: |
/s/ Adam Thomas |
| |
|
Adam Thomas, Chief Executive Officer |